Home » Stocks » Edesa Biotech » News

Edesa Biotech, Inc. (EDSA)

Stock Price: $7.97 USD 0.39 (5.15%)
Updated Aug 7, 2020 4:00 PM EDT - Market closed
After-hours: $7.98 +0.01 (0.13%) Aug 7, 7:55 PM
24/7 Wall Street - 1 week ago

Edesa Biotech Inc. (NASDAQ: EDSA) joins the list of COVID-19 stocks, as the company is making headway with regulatory agencies for its late-stage study.

Benzinga - 1 month ago

Canadian biopharma Edesa Biotech Inc (NASDAQ: EDSA) is seeing its shares surge higher Monday after it announced regulatory approval to begin a late-stage study of its investigational asset for...

Seeking Alpha - 1 year ago

Edesa Biotech received go ahead from FDA to initiate its phase 2b study using EB01 to treat patients with chronic contact dermatitis.

InvestorPlace - 1 year ago

Edesa Biotech (EDSA) stock is flying higher on Thursday after getting approval from the U.S. Food and Drug Administration (FDA).

Benzinga - 1 year ago

Edesa Biotech Inc., shares were trading higher Thursday after the company received Food and Drug Administration approval to proceed with its U.S.

Latest From StockTwits